TRIDERGEL- benzalkonium chloride gel

Tridergel by

Drug Labeling and Warnings

Tridergel by is a Otc medication manufactured, distributed, or labeled by Trifluent Pharma LLC. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

SPL UNCLASSIFIED SECTION

Drug Facts

Active Ingredients

Benzalkonium Chloride (0.1%)

Purpose

Antimicrobial

INDICATIONS & USAGE

Indications for management of:

• Stage 1-2 open wounds
• Superficial stasis ulcers
• Superficial diabetic skin ulcers
• Post-surgical incisions
• First and second-degree burns
• Cuts
• Abrasions and skin irritations

Warnings

For external use only.

When using this product avoid contact with eyes; rinse immediately with cool tap water if contact occurs.

Do not use more than the recommended dose or longer than prescribed without checking with your physician. Talk with your physician before you use any other medicines or cleansers on your skin. Ask your physician before prolonged sun exposure. If your symptoms do not improve or they worsen, contact your physician

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center (1-800-222-1222) immediately.

Directions

• Clean the wound before each application
• Apply a thin layer of Tridergel™ wound care gel to the wound surface and skin immediately surrounding the wound
• Cover the wound as directed by your physician

Inactive Ingredients

Aloe Barbadensis Leaf Juice Extract, Aminomethyl Propanol, Butylparaben, Carbomer, Decyl Glucoside, Ethylparaben, Glycerin, Hydrolyzed Eggshell Membrane, Isobutylparaben, Methylparaben, Phenoxyethanol, Propylparaben, Purified Water, Sodium Hyaluronate.

QUESTIONS OR COMMENTS

CALL (210) 944-6920

PRINCIPAL DISPLAY PANEL - 29.6 mL Bottle Label

TRIFLUENT
PHARMA®

TRIDERGEL™
WOUND CARE GEL

BENZALKONIUM CHLORIDE

IN A GEL CONTAINING
TRANSFORMING GROWTH
FACTOR – β

NDC: 73352-520-01

1.0 FL OZ (29.6 mL)

PRODUCT SHOULD BE ADMINISTERED
UNDER THE SUPERVISION OF A
LICENSED MEDICAL PRACTITIONER

INGREDIENTS AND APPEARANCE

TRIDERGEL 
benzalkonium chloride gel

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 73352-520
Route of Administration	TOPICAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
BENZALKONIUM CHLORIDE (UNII: F5UM2KM3W7) (BENZALKONIUM - UNII:7N6JUD5X6Y)	BENZALKONIUM CHLORIDE	0.001 g  in 1 mL

Inactive Ingredients
Ingredient Name	Strength
WATER (UNII: 059QF0KO0R)
EGG SHELL MEMBRANE (UNII: N7QBR4212V)
CARBOMER HOMOPOLYMER, UNSPECIFIED TYPE (UNII: 0A5MM307FC)
GLYCERIN (UNII: PDC6A3C0OX)
AMINOMETHYLPROPANOL (UNII: LU49E6626Q)
HYALURONATE SODIUM (UNII: YSE9PPT4TH)
ALOE VERA LEAF (UNII: ZY81Z83H0X)
PHENOXYETHANOL (UNII: HIE492ZZ3T)
METHYLPARABEN (UNII: A2I8C7HI9T)
ETHYLPARABEN (UNII: 14255EXE39)
ISOBUTYLPARABEN (UNII: 0QQJ25X58G)
BUTYLPARABEN (UNII: 3QPI1U3FV8)
PROPYLPARABEN (UNII: Z8IX2SC1OH)

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 73352-520-01	29.6 mL in 1 BOTTLE, WITH APPLICATOR; Type 0: Not a Combination Product	12/11/2023

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC MONOGRAPH DRUG	M003	12/11/2023

Labeler - Trifluent Pharma LLC (117167281)